Domain Ⅲ of Dengue Virus Serotype 2 Envelope: Expression at High Levels in Escherichia coli and Competitive Inhibition of Virus Entry

被引:0
|
作者
Yong-hong Yang [1 ]
Xue-li Zheng [1 ]
Lei-zi Qing [1 ]
Pin-ting Zhu [1 ]
Jing Pan [1 ]
Lei Luo [2 ]
机构
[1] Department of Etiobiology of School of Public Health and Tropical Medicine of South Medical University
[2] Guangzhou Center for Disease Control and Prevention,No.1, Qide Road of Baiyun District
基金
中国国家自然科学基金;
关键词
Dengue virus; Envelope domain Ⅲ; Virus entry; Vaccine; Neutralizing antibodies;
D O I
暂无
中图分类号
R373 [人体病毒学(致病病毒)];
学科分类号
100103 ; 100705 ;
摘要
Obejective The domainⅢof dengue virus type 2 envelope was cloned and expressed in Escherichia coli and the inhibited effects of recombinant protein on virus was detected.Methods In this study,the domainⅢ(DⅢ)protein of the dengue virus type-2(DENV-2)envelope(E)antigen was expressed in Escherichia coli by fusion with a carrier protein.The protein was purified using enzymatic cleavage and affinity purification.Rabbit immunization and antibody detection was carried out.Inhibition of DENV-2 infection was observed by DENV-2 EDⅢprotein and its immunity rabbits serum.Results The recombinant expression DENV-2 EDⅢprotein plasmid was constructed successfully.After isopropyl thiogalactoside induction,a specific soluble 29 kD protein was obtained,and the expression product
引用
收藏
页码:114 / 122
页数:9
相关论文
共 50 条
  • [21] Pathway analysis of host responses to dengue virus serotype 2 infection and inhibition of viral envelope protein by naringenin from Ganoderma lucidum
    Lim, Wui Zhuan
    Chang, Siow Wee
    Teoh, Teow Chong
    JOURNAL OF BIOSCIENCES, 2023, 48 (04)
  • [22] Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo
    Williams, Katherine L.
    Wahala, M. P. B. Wahala
    Orozco, Susana
    de Silva, Aravinda M.
    Harris, Eva
    VIROLOGY, 2012, 429 (01) : 12 - 20
  • [23] Simple production of hydrophobin-fused domain III of dengue envelope protein and induction of neutralizing antibodies against the homotypic serotype of dengue virus
    Cerezo, Julieta
    Marisa Targovnik, Alexandra
    Emilia Smith, Maria
    Gonzalez Maglio, Daniel
    Celina Luppo, Victoria
    Alejandra Morales, Maria
    Victoria Miranda, Maria
    Rodriguez Talou, Julian
    BIOTECHNOLOGY LETTERS, 2020, 42 (03) : 419 - 428
  • [24] Thioaptamers targeting dengue virus type-2 envelope protein domain III
    Gandham, Sai Hari A.
    Volk, David E.
    Lokesh, Ganesh L. R.
    Neerathilingam, Muniasamy
    Gorenstein, David G.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 453 (03) : 309 - 315
  • [25] Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-Mediated antibody-dependent enhancement of infection
    Chotiwan, Nunya
    Roehrig, John T.
    Schlesinger, Jacob J.
    Blair, Carol D.
    Huang, Claire Y. -H.
    VIROLOGY, 2014, 456 : 238 - 246
  • [26] Optimization of Conditions for Expression of Dengue Serotype 2 EDIII Protein in Escherichia coli and Immune Responses of Adjuvant-Free EDIII Ferritin Nanoparticles Against Dengue Virus in BALB/c Mice
    Tennakoon, M. S. B. W. T. M. Nipuna Sudaraka
    Lee, Kyoung-Ho
    Lee, Hye-Mi
    Park, Jae-Yeon
    Shin, Hyun-Jin
    VIRUSES-BASEL, 2025, 17 (01):
  • [27] Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates
    McBurney, Sean P.
    Sunshine, Justine E.
    Gabriel, Sarah
    Huynh, Jeremy P.
    Sutton, William F.
    Fuller, Deborah H.
    Haigwood, Nancy L.
    Messer, William B.
    VACCINE, 2016, 34 (30) : 3500 - 3507
  • [28] Blocking the dengue virus 2 infections on BHK-21 cells with purified recombinant dengue virus 2 E protein expressed in Escherichia coli
    Chiu, MW
    Yang, YL
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 309 (03) : 672 - 678
  • [29] Expression and Purification of Recombinant Envelope (rE) Protein of Dengue Virus in Escherichia coli BL21(DE3) with Computational Analysis
    Damara, Bonifasius Kevin Dio Yogi
    Purnamasari, Elly Widyarni Eka
    Nissa, Khairun
    Wibowo, Syahputra
    Pratiwi, Rarastoeti
    Kusumawati, Asmarani
    INDONESIAN JOURNAL OF PHARMACY, 2025, 36 (01): : 96 - 105
  • [30] High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice
    Zhang, Zhi-Shan
    Yan, Yan-Sheng
    Weng, Yu-Wei
    Huang, Hai-Long
    Li, Shi-Qing
    He, Shi
    Zhang, Jian-Ming
    JOURNAL OF VIROLOGICAL METHODS, 2007, 143 (02) : 125 - 131